BGH BGH
Company Profile ↓Company Overview
BGH (BGH) is a publicly traded company listed on with a market capitalization of $283.76M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 6.7.
Maintains a net profit margin of 91.2%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $22.04M (-50.1% YoY); net profit $20.09M.
- Trailing 12 Months Year-on-year growth — revenue -50.1%, earnings -52.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -50.07% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -52.24% |
Stock Price Performance
| 1 Year: | -5.56% |
| 6 Months: | +5.55% |
| 3 Months: | +4.24% |
| 1 Month: | +0.36% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)51.71 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 91.2%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | -45.58M | 49.82M | 44.14M | 22.04M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 1.63M | 2.12M | 2.08M | 1.95M |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 2.54M | 6.11M | 7.13M | 6.56M |
| Pretax Income | - | -47.20M | 47.70M | 42.06M | 20.09M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -47.20M | 47.70M | 42.06M | 20.09M |
| Diluted EPS | 2.47 | -2.35 | 2.37 | 2.10 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 399.28M | 427.49M | 474.87M | 446.43M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 5.41M | 14.65M | 8.29M | 5.78M |
| Inventory | - | - | - | - | - |
| Receivables | - | 10.24M | 10.75M | 12.94M | 9.74M |
| Total Liabilities | - | 113.23M | 122.51M | 157.93M | 143.42M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 108.50M | 109.50M | 144.50M | 137.50M |
| Total Equity | - | 286.04M | 304.98M | 316.94M | 303.02M |
| Shares Outstanding | - | 20.06M | 20.06M | 20.06M | 20.08M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 48.06M | 35.33M | -6.68M | 37.55M |
| Investing Cash Flow | - | - | - | - |
| Financing Cash Flow | -49.43M | -27.76M | 5.23M | -41.01M |
| Capital Expenditure | - | - | - | - |
| Free Cash Flow | 48.06M | 35.33M | -6.68M | 37.55M |
| Net Change in Cash | -1.37M | 7.57M | -1.45M | -3.46M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 103.6% | 95.7% | 95.3% | 91.2% |
| ROE % | - | -16.5% | 15.6% | 13.3% | 6.6% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BGH
Babson Capital Global Short Duration High Yield Fund (BGH) Stock Price, News, Earnings & Company Profile - RTTNews
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNRGFraW1TTldCVXZ0RjYtOEN5MjhPT0xqYV9LekVpN2FXWm5PS1hrNHhEZ3VZNVNhWkM1X21uUE4tbkptM283VERUdm5ONlpwLVhLRS1iaXd6ZEU5eDFnNGlRMndpY0tGcGE0YUplNWJaNEhXZzJreEhwYzlQaHdHQWlFejBhcUFOVDQ2UV…
High-yield fund (NYSE: BGH) lines up new raise on a leveraged ‘junk’ bond portfolio - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQTW1ESENaQWppQ2JySVU2RDEzQkF6NE1MOGpZdWJKZzc5QlNyamxoV2MySTNISW1iMlhKLVQxY1ZGWWc1YUxJd2hjdVhQMFpVbWhPWEo3NjBDUWJ1SkIzTUphWXNtdlduUld6OFJyY1ZKVlFjY0xXVEJ5MkZxb1NxY2pSbkI4dmJ1OVNxYm…
BGH: 9%-Plus Yield On Short Term Assets (NYSE:BGH) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQU2ExU1RZNnlkMWk3RnVmOE1xLVJfMkt1WEhzMzFpMTB5VzZhTTd4aE1IT2gyVUNUVmExMGhKNU5zQU0zczY2Z0V5R1M1MG5Vc2d0REFtQmczckd6X1FyWml4cUxpU000N1dsbGFkQjlCZE5CU2x6VmRsdTBvYkZnbGtQUnRMSC00YWFzcV…
BGH’s 10.46% Annualized Yield Comes With Two Estimated Payments - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPNUVXcHNFaEdOSXVoRVpPdFQ4a1gwNWktN1VvaWNtTHNvVDFPaVBVSVVnY3I0V21jaF9Vd0FZZ211bVRTbHdtT04yakxlNDhlc1hQRXU2Sy0tSnRrVWZHNURfcEd3MzNkbUpOUmRwUWNvSW8xV2ZJNDJBNEdlM0UzUzBiRnVoOUdtMWVIdE…
EQT Holdings (ASX:EQT) Attracts Takeover Interest From TPG and BGH Capital - Kalkine
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNb1ktODlCaUF5cmJJdXF5R3gxTG80cVBfNWtoY3k5alBFY3ZzVVJ2UWttQ2F1Sm9qMzBSaVYzRHNOWGQ1Z0YydzlPQVc3eHdUa1BqV0k4R2t0RnBvWnY5ZzVsZUpCcHJMVk0zTkRTSDBrNFV1NDdiSnFyODA0bzZPc0VwQTdFbXFVbGhHX2…
Aspen Pharmacare to sell Asia Pacific assets to BGH Capital for $1.59 billion - Investing.com
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxQTllsRE4wWTB5N29IM2ZtVnhYNWpQOEZNc19zOGY5U1V6V0pTNG9abnM1cjlKUjNudkNCeWNGWFY1TlcySFZpcDQydDFFV3M3UU1zX3JITlRtSGV2ODNzZHVOek5sd0R1YjZULWZWTDNhSnZHcnFCY1plYjJHRTNncHVPZnJWLTRxWU56dE…
BGH — Frequently Asked Questions
What is the current share price of BGH?
As of 2026-09-07 16:24 PDT, BGH trades at $14.13 on NASDAQ/NYSE. Its 52-week range is $12.63 to $15.21.
What is the market capitalisation of BGH?
BGH has a market capitalisation of $283.76M on NASDAQ/NYSE.
What is the P/E ratio of BGH?
BGH trades at a trailing price-to-earnings (P/E) ratio of 6.73. Its price-to-book (P/B) ratio is 0.94.
What is the return on equity (ROE) of BGH?
BGH has a return on equity (ROE) of 6.63%.
Is BGH a good stock to buy?
This page provides a data-driven analysis of BGH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.